1. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001; 286:1317–1324. PMID:
11560536.
Article
2. Goodney PP, Tarulli M, Faerber AE, Schanzer A, Zwolak RM. Fifteen-year trends in lower limb amputation, revascularization, and preventive measures among medicare patients. JAMA Surg. 2015; 150:84–86. PMID:
25409197.
Article
3. Elagizi A, Kachur S, Lavie CJ, et al. An overview and update on obesity and the obesity paradox in cardiovascular diseases. Prog Cardiovasc Dis. 2018; 61:142–150. PMID:
29981771.
Article
4. Park D, Lee JH, Han S. Underweight: another risk factor for cardiovascular disease?: a cross-sectional 2013 Behavioral Risk Factor Surveillance System (BRFSS) study of 491,773 individuals in the USA. Medicine (Baltimore). 2017; 96:e8769. PMID:
29310352.
5. Golledge J, Cronin O, Iyer V, Bradshaw B, Moxon JV, Cunningham MA. Body mass index is inversely associated with mortality in patients with peripheral vascular disease. Atherosclerosis. 2013; 229:549–555. PMID:
23742964.
Article
6. Keller K, Hobohm L, Geyer M, et al. Obesity paradox in peripheral artery disease. Clin Nutr. 2019; 38:2269–2276. PMID:
30322783.
Article
7. Ludhwani D, Wu J. Obesity paradox in peripheral arterial disease: results of a propensity match analysis from the national inpatient sample. Cureus. 2019; 11:e4704. PMID:
31249770.
Article
8. Ko YG, Ahn CM, Min PK, et al. K-VIS investigators. Baseline characteristics of a retrospective patient cohort in the korean vascular intervention society endovascular therapy in lower limb artery diseases (K-VIS ELLA) registry. Korean Circ J. 2017; 47:469–476. PMID:
28765738.
Article
9. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000; 894:i–ixii. PMID:
11234459.
10. Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Circulation. 2018; 138:e618–e651. PMID:
30571511.
Article
11. Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013; 44:2064–2089. PMID:
23652265.
12. Murata N, Soga Y, Iida O, et al. Complex relationship of body mass index with mortality in patients with critical limb ischemia undergoing endovascular treatment. Eur J Vasc Endovasc Surg. 2015; 49:297–305. PMID:
25524520.
Article
13. Moussa Pacha H, Al-Khadra Y, Darmoch F, et al. Association between underweight body mass index and in-hospital outcome in patients undergoing endovascular interventions for peripheral artery disease: a propensity score matching analysis. J Endovasc Ther. 2019; 26:411–417. PMID:
30931727.
Article
14. Kim M, Kim MA, Kim HL, et al. Body mass index and the risk of low femoral artery puncture in coronary angiography under fluoroscopy guidance. Medicine (Baltimore). 2018; 97:e0070. PMID:
29489670.
Article
15. Cox N, Resnic FS, Popma JJ, Simon DI, Eisenhauer AC, Rogers C. Comparison of the risk of vascular complications associated with femoral and radial access coronary catheterization procedures in obese versus nonobese patients. Am J Cardiol. 2004; 94:1174–1177. PMID:
15518615.
Article
16. Hackl G, Gary T, Belaj K, Hafner F, Eller P, Brodmann M. Risk factors for puncture site complications after endovascular procedures in patients with peripheral arterial disease. Vasc Endovascular Surg. 2015; 49:160–165. PMID:
26429973.
Article
17. Kumakura H, Kanai H, Aizaki M, et al. The influence of the obesity paradox and chronic kidney disease on long-term survival in a Japanese cohort with peripheral arterial disease. J Vasc Surg. 2010; 52:110–117. PMID:
20478682.
Article
18. Abramowitz MK, Hall CB, Amodu A, Sharma D, Androga L, Hawkins M. Muscle mass, BMI, and mortality among adults in the United States: a population-based cohort study. PLoS One. 2018; 13:e0194697. PMID:
29641540.
Article
19. Maeda K, Ishida Y, Nonogaki T, Mori N. Reference body mass index values and the prevalence of malnutrition according to the Global Leadership Initiative on Malnutrition criteria. Clin Nutr. 2020; 39:180–184. PMID:
30712782.
Article
20. Zamboni M, Mazzali G, Zoico E, et al. Health consequences of obesity in the elderly: a review of four unresolved questions. Int J Obes. 2005; 29:1011–1029.
Article
21. Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis. 2003; 42:864–881. PMID:
14582032.
Article
22. Kobayashi Y, Kobayashi H, Fujikawa T, et al. A2230 High prevalence of sarcopenia in peripheral artery disease patients: a cross-sectional study of patients with life-style related diseases. J Hypertens. 2018; 36:e94–e95.
23. Matsubara Y, Matsumoto T, Aoyagi Y, et al. Sarcopenia is a prognostic factor for overall survival in patients with critical limb ischemia. J Vasc Surg. 2015; 61:945–950. PMID:
25498160.
Article
24. Abou-Samra M, Selvais CM, Dubuisson N, Brichard SM. Adiponectin and its mimics on skeletal muscle: insulin sensitizers, fat burners, exercise mimickers, muscling pills … or everything together? Int J Mol Sci. 2020; 21:2620.
Article
25. Abramowitz MK, Hall CB, Amodu A, Sharma D, Androga L, Hawkins M. Muscle mass, BMI, and mortality among adults in the United States: a population-based cohort study. PLoS One. 2018; 13:e0194697. PMID:
29641540.
Article
26. Mizobuchi K, Jujo K, Minami Y, Ishida I, Nakao M, Hagiwara N. The baseline nutritional status predicts long-term mortality in patients undergoing endovascular therapy. Nutrients. 2019; 11:1745.
Article